EmilMdeGomaMD

PubMed

• 7 citations
  A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia
  Ezimamaka Ajufo, Emil M. deGoma, Anna Raper, Kristen Dilzell Yu, Marina Cuchel, Daniel J. Rader> ;Genetics in Medicine. 2021 May 26
• 30 citations
  Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese...
  Masaomi Nangaku, Youssef M.K. Farag, Emil M. deGoma, Wenli Luo, Dennis Vargo, Zeeshan Khawaja> ;Nephrology, Dialysis, Transplantation. 2021 Jun 28
• 55 citations
  Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
  Volker H. Haase, Glenn M. Chertow, Geoffrey A. Block, Pablo E. Pergola, Emil M. deGoma, Zeeshan Khawaja, Amit Sharma, Bradley J. Maroni, Peter A. McCullough> ;Nephrology, Dialysis, Transplantation. 2019 Jan 1
• 26 citations
  A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis.
  Masako Ueda, Richard L. Dunbar, Anna Wolska, Tracey Sikora, Maria Escobar, Naomi Seliktar, Emil M. deGoma, Stephanie DerOhannessian, Linda Morrell, Adam D. McIntyre, F...> ;The Journal of Clinical Endocrinology and Metabolism. 2017 May 1
• 18 citations
  Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E.
  John S. Millar, Michael E. Lassman, Tiffany Thomas, Rajasekhar Ramakrishnan, Patricia Jumes, Richard L. Dunbar, Emile M. deGoma, Amanda Baer, Wahida Karmally, Daniel S...> ;Journal of Lipid Research. 2017 Mar 17
• 99 citations
  Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
  Edouard R. Martin, Mark T. Smith, Bradley J. Maroni, Qing C. Zuraw, Emil M. deGoma> ;American Journal of Nephrology. 2017 Mar 25
• 45 citations
  US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
  Zahid Ahmad, Rolf Andersen, Lars Andersen, Emily C. O'Brien, Iris Kindt, Peter Shrader, Chandna Vasandani, Connie B. Newman, Emil M. deGoma, Seth J. Baum, Linda C. Hem...> ;Journal of Clinical Lipidology. 2016 Sep 1
• 12 citations
  Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
  Patrick M. Moriarty, Klaus G. Parhofer, Stephan P. Babirak, Emil M. deGoma, P. Barton Duell, Bernd Hohenstein, Wolfgang Ramlow, Vinaya Simha, Elisabeth Steinhagen-Thie...> ;Journal of Clinical Lipidology. 2016 May 1
• 6 citations
  Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.
  John S Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L Dunbar, Emil M deGoma, Amanda L Baer, Wahida Karmally, Daniel S Donovan, Hashmi Rafeek, Laura Pollan, J...> ;The Journal of Clinical Investigation. 2016 Apr 1
• 148 citations
  Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
  Emil M. deGoma, Zahid Ahmad, Emily C. O'Brien, Iris Kindt, Peter Shrader, Connie B. Newman, Yashashwi Pokharel, Seth J. Baum, Linda C. Hemphill, Lisa C. Hudgins, Cathe...> ;Circulation. Cardiovascular Genetics. 2016 Mar 24
• Beyond Blood Pressure: Percutaneous Renal Denervation for the Management of Sympathetic Hyperactivity and Associated Disease States.
  McArdle, M. J., deGoma, E. M., Cohen, D. L., Townsend, R. R., Wilensky, R. L., Giri, J.> ;Journal of the American Heart Association. 2016 Jan 6
• 29 citations
  Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholester...
  Gissette Reyes-Soffer, John S. Millar, Colleen Ngai, Patricia Jumes, Ellie Coromilas, Bela F. Asztalos, Amy O. Johnson-Levonas, John A. Wagner, Daniel S. Donovan, Wahi...> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2016 Jan 1
• 2 citations
  Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.
  John S Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L Dunbar, Emil M deGoma, Amanda L Baer, Wahida Karmally, Daniel S Donovan, Hashmi Rafeek, Laura Pollan, J...> ;The Journal of Clinical Investigation. 2015 Jun 1
• 2 citations
  A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
  Emil M. deGoma, Ali Salavati, Russell T. Shinohara, Babak Saboury, Laura Pollan, Marisa Schoen, Drew A. Torigian, Emile R. Mohler, Richard L. Dunbar, Harold Litt, John...> ;Academic Radiology. 2015 May 1
• 5 citations
  Updated cholesterol guidelines and intensity of statin therapy.
  Vincent Nguyen, Emil M. deGoma, Erik Hossain, Douglas Jacoby> ;Journal of Clinical Lipidology. 2015 May 1
• 5 citations
  Carotid intima-media thickness measurement promises to improve cardiovascular risk evaluation in head and neck cancer patients.
  Douglas Jacoby, Jihane Hajj, Ali Javaheri, Emil deGoma, Alexander Lin, Peter H. Ahn, Harry Quon> ;Clinical Cardiology. 2015 May 1
• 3 citations
  Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.
  Michael J McArdle, Emil M deGoma, Debbie L Cohen, Raymond R Townsend, Robert L Wilensky, Jay Giri> ;Journal of the American Heart Association. 2015 Mar 23
• 16 citations
  Statins and Cognitive Function: an Updated Review
  Saurav Chatterjee, Parasuram Krishnamoorthy, Pragya Ranjan, Ahana Roy, Anasua Chakraborty, Manpreet Singh Sabharwal, Richard Ro, Vikram Agarwal, Partha Sardar, Jacquel...> ;Current Cardiology Reports. 2015 Jan 25
• Correction to "lomitapide for the management of homozygous familial hypercholesterolemia".
  Emil M. deGoma> ;Reviews in Cardiovascular Medicine. 2014 Jan 1
• 11 citations
  Lomitapide for the management of homozygous familial hypercholesterolemia.
  Emil M. deGoma> ;Reviews in Cardiovascular Medicine. 2014 Jun 30
• 48 citations
  Loss of von hippel-lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis
  Sadeesh K. Ramakrishnan, Matthew Taylor, Aijuan Qu, Sung-Hoon Ahn, Madathilparambil V. Suresh, Krishnan Raghavendran, Frank J. Gonzalez, Yatrik M. Shah> ;Molecular and Cellular Biology. 2014 Apr 1
• 51 citations
  Future of Cholesteryl Ester Transfer Protein Inhibitors
  Daniel J. Rader, Emil M. deGoma> ;Annual Review of Medicine. 2014 Jan 14
• 174 citations
  Statins and Cognitive Function: A Systematic Review
  Karl Richardson, Marisa Schoen, Benjamin French, Craig A Umscheid, Matthew D. Mitchell, Steven E. Arnold, Paul A. Heidenreich, Daniel J. Rader, Emil M. deGoma> ;Annals of Internal Medicine. 2013 Nov 19
• 27 citations
  Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis.
  Emil M. deGoma, Mat D. Davis, Richard L. Dunbar, Emile R. Mohler, Philip Greenland, Benjamin French> ;Atherosclerosis. 2013 Aug 1
• 283 citations
  Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
  Francesco Locatelli, Peter Bárány, Adrian Covic, Angel L.M. de Francisco, Lucia Del Vecchio, David Goldsmith, Walter H. Hörl, Gérard M. London, Raymond Vanholder, Wim ...> ;Nephrology, Dialysis, Transplantation. 2013 Jun 1
• Join now to see all

Journal Articles

• Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis.  
  deGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ, Atherosclerosis 2012;224:274-9
• Targeting high density lipoproteins in the prevention of cardiovascular disease.  
  Larach D, deGoma EM, Rader DJ, Curr Cardiol Rep
• Approach to the Patient with Extremely Low HDL- Cholesterol.  
  Rader DJ, deGoma EM, J Clin Endocrinol Metab 2012;97:3399-407
• The underappreciated impact of heart disease.  
  deGoma EM, Karlsberg RP, Judelson DR, Budoff MJ, Women’s Health Issues 2010;20:299-303
• Extremely elevated lipoprotein(a), combined hyperlipidemia, and premature atherosclerosis in a Chinese family.  
  deGoma EM, Wheeler MT, Marcovina S, Ashley EA, J Clin Lipidol 2010;4:543-7
• Surgically corrected right-sided aortic arch.  
  deGoma EM, Wright CD, Pelikan PC, Leal JE, Karlsberg RP, J Am Coll Cardiol 2011;57:2375
• Guidewire embolization and right ventricular perforation visualized by cardiac CT.  
  deGoma EM, Goldberg NJ. Karlsberg RP, J Cardiovasc Comput Tomogr 2011;5:61
• HDL particle number: A better biomarker to quantify HDL?  
  deGoma EM, Rader DJ, J Am Coll Cardiol 2012;60:517-20
• HDL-targeted therapies: Where do we go from here?  
  Rader DJ, deGoma EM, Lipid Spin
• Join now to see all

Books/Book Chapters

• Comprehensive Management of High Risk Cardiovascular Patients. 
  Chapter: Peripheral arterial disease 
  deGoma EM, Rockson SGEditors: Toth PP, Gotto AM, Jr.Informa Healthcare, New York
• Atlas of Vascular Medicine: A Case-Based Approach to Current Management. 
  Chapter: Penetrating Atherosclerotic Ulcer and Intramural Hematoma 
  deGoma EM, Moulik S, Rovno SEditors: ER Mohler III.Demos Medical Publishing, New York
• Atlas of Vascular Medicine: A Case-Based Approach to Current Management. 
  Chapter: Type A Acute Aortic Dissection 
  Shiran H, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
• Atlas of Vascular Medicine: A Case-Based Approach to Current Management. 
  Chapter: Type B Acute Aortic Dissection 
  Shiran H, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
• Atlas of Vascular Medicine: A Case-Based Approach to Current Management. 
  Chapter: Abdominal Aortic Aneurysm 
  Lilly SM, Moulik S, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
• Atlas of Vascular Medicine: A Case-Based Approach to Current Management. 
  Chapter: Thoracic Aortic Aneurysm 
  Yuriditsky E, Rovno S, deGoma EMEditors: ER Mohler III.Demos Medical Publishing, New York
• American College of Cardiology Self-Assessment Program 8. 
  Chapter: Atherosclerosis Risk Assessment 
  deGoma EM, Polk DMEditors: DM Polk, P.T. O’Gara.American College of Cardiology, Washington, D.C
• American College of Cardiology Self-Assessment Program 8. 
  Chapter: Board Review Questions 
  deGoma EM, Polk DMEditors: DM Polk, P.T. O’Gara.American College of Cardiology, Washington, D.C
• Join now to see all

Abstracts/Posters

• Clinical significance of HDL-C levels among patients with LDL-C < 60 mg/dL.
  deGoma EM, Leeper NJ, Heidenreich PA, AHA Scientific Sessions
• Statin use in patients with low LDL-C is associated with improved survival.
  Leeper NJ, Ardehali R, deGoma EM, Heidenreich PA, AHA Scientific Sessions

Lectures

• Subclinical atherosclerosis imaging. 
  Perelman School of Medicine at the University of Pennsylvania. Cardiology Grand Rounds. Philadelphia
• Coronary artery calcium scanning for cardiovascular risk refinement. 
  Perelman School of Medicine at the University of Pennsylvania. Medicine Grand Rounds. Philadelphia